The global Open Loop Artificial Pancreas market size is predicted to grow from US$ 1612 million in 2025 to US$ 2551 million in 2031; it is expected to grow at a CAGR of 8.0% from 2025 to 2031.
Open loop artificial pancreas is a relatively simple but effective medical device for diabetes management. Its core function is to simulate the insulin secretion mechanism of healthy pancreas. Unlike closed-loop systems, open-loop artificial pancreas does not have blood glucose sensors, but is mainly composed of two core parts: a microcomputer and an insulin injection pump. This system design simplifies its structure, reduces its size, and makes it easier for patients to carry and use.
Segmentation by Type:
- Basic Insulin Pump System
- CGM Insulin Pump Linkage System
- Threshold Pause System
Segmentation by Application:
- Type 1 Diabetes Management
- Type 2 Diabetes Intensive Treatment
- Clinical Research Transitional Stage
Market by Region:
- Americas
- APAC
- Europe
- Middle East & Africa
Companies Coverage:
- Roche
- Insulet
- Tandem Diabetes Care
- Johnson And Johnson
- Abbott Laboratories
- Ypsomed
- Dexcom
- Medtronic
- Medtrum Technologies
- MicroTech Medical
- Sansure Medical
- Medlinket Medical Technology
- SiBionics
Key Questions Addressed in this Report:
- What is the 10-year outlook for the global Open Loop Artificial Pancreas market?
- What factors are driving Open Loop Artificial Pancreas market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Open Loop Artificial Pancreas market opportunities vary by end market size?
- How does Open Loop Artificial Pancreas break out by Type, by Application?
Frequently Asked Questions
What is the USP of the report? expand_more
What are the key content of the report? expand_more
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market